Get started
Live feed
PRReleasevia Quantisnow
Acurx Pharmaceuticals Inc. logo

Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ACXP

Across the 8 sessions after earlier ACXP headlines, the stock closed higher 6 times and lower 2 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ACXP close-to-close change in the session after earlier headlines
SessionEarlier headlineACXPSPY
Mar 9, 2026Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection+44.8%+0.9%
Feb 17, 2026Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update+0.5%+0.2%
Feb 2, 2026USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors+0.6%+0.5%
Nov 18, 2025Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals+2.8%-0.8%
Nov 12, 2025Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update-10.8%+0.1%
Nov 10, 2025Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens+11.0%+1.6%
Quantisnow market dataNASDAQ
Acurx Pharmaceuticals Inc. logo
ACXP
Acurx Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for ACXP

Follow ACXP and get a push notification the moment its next story breaks.

Full ACXP profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACXP (Acurx Pharmaceuticals Inc.) and more on Quantisnow.